【Composition and Performance】
The material is derived from animals of major pet categories through legal channels. It is processed through cutting, crushing, cleaning to remove bone marrow, chemical treatment to remove immunogenicity and/or decalcification, freeze-drying, and irradiation sterilization. The main components are calcium phosphate salts, collagen, and osteogenic proteins. When applied to the same type of animal, the product forms new bone and heals with the recipient bone through osteoconduction and osteoinduction. The newly grown bone replaces the implant material, which is gradually absorbed. The natural bone implant material (≥30%) is mixed with glycerol etc.as a shaping agent. The glycerol etc.component is consistent with FDA-registered and marketed products of the same type. It is absorbable and is beneficial for new bone growth.
【Indications for Use】
For filling bone defects caused by tumors or trauma, and bone grafting in spinal and joint fusion surgeries. Particularly suitable for minimally invasive and precise bone grafting under laparoscopy.
Location of the Wuhan R&D headquarters: No.97, Gaoke 2nd Road, East Lake High- Tech Development Zone, Wuhan.
Location of the laboratory in Hong Kong: 6 Science Park West Road, HKSTP.
Tel: 027-63498011 (Wuhan) 085268466734 (Hong Kong)
Email: info@leadermed-biotech.com
Follow Us